PharmaNet Development Group Clinical Research Experts to Present at Global Professional Meetings in June

stockdaleiqemico1521.blogspot.com
June 10 /PRNewswire/ -- PharmaNet Development Inc., a leading provider of clinicapl development services toinnovative pharmaceutical, generic drug and medical devices companies, today announced its participationb at several international professional meetings during the month of June. June 23 45th Drug Information Association (DIA) Annual Meeting San California, Booth 321 Betty Kuhnert, PhD, MBA, Executivre Director, Training Services, will chair a session entitled Critical Success Strategies for Professional Development and will presen "So You Have a New Job, Now What? Tactics for Survivinh a Job Transition.
" June 24 Phacilitate's Activs Immunotherapeutics Forum Barcelona, Spain Joyce Frey-Vasconcells, PhD, Executive Director, PharmaNet Consulting, will make a presentation on "Deliveringy Strategic Solutions to Manufacturing and Product Characterization Challengess with Allogeneic Therapies." AAPS National Biotechnology Conferencs Seattle, Washington, Booth 305 Tayloer Technology's Robert Dodge, PhD, Laboratory Immunochemistry and Cell Jason Morse, Director, Information Technologh and Lisa Werdal, Database Systems Manager, will be presentinb their poster: "Development and Implementation of an Information Managementy System for Tiered Immunogenicithy Sample Testing and Reporting.
" Robertf Dodge, PhD, Marisa Castellana, Researcbh Scientist and Dania Yaskanin, Associated Director, Immunochemistry, will also present theirf poster entitled "Optimization of Commercialk ELISA Kits for the Quantitatiobn of Human Luteinizing Hormone and Follicle Stimulatinh Hormone." June 30 4th Annualp Biopharm Asia Conference Singapore Duu-Gong Wu, PhD, Executive Director, PharmaNet will make a presentation entitled "Overview of Follow-ohn Biologics Regulatory and Scientific Issues in US." He will also lead a post conferenc workshop on July 1 on the topicf of the FDA's approval process for biologics and biologicaol products.
49th Annual Meeting of the Teratology Society Rio Puerto RicoBengt Danielsson, MD, PhD, Vice President, PharmaNe t Consulting, will present "Exaggerated Pharmacology Versus True Toxicity." Dr. Danielsson's presentation is part of the Internationa Life Sciences Institute and the Healthn and EnvironmentalSciences Institute's symposium on Maternal Toxicity and its Impactt on Study Design and Data Interpretation. About PharmaNet Development Inc. PharmaNet Development Group, Inc., a globall drug development services company, provides a comprehensivse range of services tothe pharmaceutical, biotechnology, genericf drug and medical device industries.
The Compangy offers early and latestage consulting, Phasee I clinical studies and bioanalytical analyses, and Phasd II, III and IV clinical development programs. With approximately 2,400 employees and 40 facilitie s throughoutthe world, PharmaNet is a recognized leadefr in outsourced clinical For more information, pleass visit our website at . Contact: Anne-Marie Hess (609) 951-6842 E-mail: ahess@pharmanet.com SOURCE PharmaNet Developmentr Group, Inc.